Department of Women's and Children's Health, "Agostino Gemelli" Foundation University Hospital, Catholic University, Rome, Italy.
Department of Women's and Children's Health, "Agostino Gemelli" Foundation University Hospital, Catholic University, Rome, Italy.
Gynecol Oncol. 2018 Jul;150(1):203-204. doi: 10.1016/j.ygyno.2018.04.568. Epub 2018 May 3.
Video endoscopy inguinal lymphadenectomy (VEIL) has emerged as the new frontier for the surgical staging of vulvar cancer (VC) [1, 2]. In this surgical film we show a step-by-step video presentation of a Robotic SLNmapping using ICG (Canadian Task Force classification III). Although the therapeutic benefit of SLN remains controversial in clinical N0 (cN0) with VC N 4 cm [3], it provides prognostic information that can guide further adjuvant treatment. Robotic sentinel lymphnode (SLN) mapping using indocyanine green (ICG) appears to be a suitable and attractive alternative to provide reliable staging with respect to other tracers [3, 4].
A 75-year-old severely obesewoman (BMI:47.8 kg/m2) with squamous VC grading 3, clinical stage II (cT = 5 cm, cN0, cM0) and with a pre-operative PET-CT scan negative for metastatic localizations, was admitted for surgery. Surgical staging was performed including radical vulvectomy with macroscopic resection margins larger than 2 cm., SLN mapping with ICG followed by systematic inguinal lymphadenectomy. Da Vinci Xi System® was used to perform it.
The operation was performed successfully with no intraoperative or postoperative complication. Operative time was 310 min overall. Twenty-five inguinal lymph nodes were removed (11 on the left, 14 on the right). The pathology report came back positive for SLN removed. The patient was discharged on day #4 and 20 days later started adjuvant radiochemotherapy.
SLN with ICG is robotically feasible. However, we notice that further prospective trials are needed to compare ICG with other colorimetric and/or radioactive tracers in this subset of patients.
视频内镜腹股沟淋巴结切除术(VEIL)已成为外阴癌(VC)手术分期的新前沿[1,2]。在这部手术影片中,我们展示了使用吲哚菁绿(ICG)进行机器人 SLN 映射的分步视频演示[加拿大工作队分类 III]。尽管 SLN 的治疗益处在临床 N0(cN0)中仍存在争议,对于 VC N 4 cm[3],但它提供了可以指导进一步辅助治疗的预后信息。使用吲哚菁绿(ICG)的机器人前哨淋巴结(SLN)映射似乎是一种合适且有吸引力的替代方法,可以相对于其他示踪剂提供可靠的分期[3,4]。
一名 75 岁的严重肥胖女性(BMI:47.8 kg/m2)患有鳞状 VC 分级 3,临床分期 II(cT = 5 cm,cN0,cM0),术前 PET-CT 扫描无局部转移定位,入院接受手术。手术分期包括广泛外阴切除术,切除宏观边缘大于 2 cm 的肿瘤,使用 ICG 进行 SLN 映射,然后进行系统腹股沟淋巴结切除术。使用 Da Vinci Xi System® 进行操作。
手术过程顺利,无术中或术后并发症。总手术时间为 310 分钟。共切除 25 个腹股沟淋巴结(左侧 11 个,右侧 14 个)。病理报告显示 SLN 阳性。患者于第 #4 天出院,20 天后开始辅助放化疗。
ICG 的 SLN 是可行的机器人操作。然而,我们注意到需要进一步的前瞻性试验来比较 ICG 与其他比色和/或放射性示踪剂在这组患者中的应用。